Omnicell (OMCL) risk factors
Item 1A of every Omnicell, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors52 risks6 new1 dropped17 reworded
Omnicell added new risk disclosures around 2025 tariffs, customer lease financing, and cash concentration limits. Disclosures were updated to reference the new Titan XT cabinet and DOJ data security rules.
Filed Feb 26, 2026 - FY2024 10-K risk factors47 risks
Omnicell faces significant risks from economic downturns impacting capital equipment demand for its medication management systems. The transition to subscription-based SaaS and Expert Services introduces complex operational, billing, and retention challenges. The company depends heavily on single-source suppliers and continuous operations at its St. Petersburg, Florida packaging facility. Strict regulatory oversight governs healthcare, data privacy, and the 340B Drug Pricing Program.
Filed Feb 27, 2025